IQ-AI, the healthcare technology and software holding company formerly known as Flying Brands, announced it has filed a patent for MR imaging that does not use gadolinium-based contrast agents (GBCAs).

A team from the Walter and Eliza Hall Institute of Medical Research in Parkville, Victoria, Australia, has used single cell imaging and color-changing sensors to uncover new information about how the cell cycles of cancer cells are disrupted.

Spanish-speaking women are faced with unique challenges when receiving information such as dense breast notifications (DBN) and mammogram results, according to new research published in the Journal of General Internal Medicine.

A team of researchers has developed a new wireless “bio-patch” that can provide an early warning when there are signs a patient’s breast reconstruction surgery may have not been a success.

The World Health Organization (WHO) cites breast cancer as being one of the top cancers affecting Bangladeshi women due to the social stigma attached to speaking about reproductive health, according to reporting from the Dhaka Tribune.

GE Healthcare and Aga Khan University Hospital (AKUH) in Nairobi, Kenya, hosted a PET/CT and Cyclotron Symposium Oct. 25 in Nairobi to drive the discussion of early cancer diagnosis and detection.

Novarad’s OpenSight Augmented Reality (AR) System is the first AR solution for Microsoft HoloLens to receive FDA clearance for pre-operative surgical planning, the company announced this week.

For the team at Roper Radiologists PA (RR) in Charleston, South Carolina, organization plays a pivotal role. And in 2017, the practice found itself at a bit of a crossroads. They wanted more advanced tools at their fingertips for assigning reads and filtering worklists, but they felt limited by their available tools.